Literature DB >> 12842952

Safety and feasibility of prehospital thrombolysis carried out by paramedics.

Phil Keeling1, Debbie Hughes, Linnie Price, Steve Shaw, Andy Barton.   

Abstract

Mesh:

Year:  2003        PMID: 12842952      PMCID: PMC164238          DOI: 10.1136/bmj.327.7405.27

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

Authors:  L J Morrison; P R Verbeek; A C McDonald; B V Sawadsky; D J Cook
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors:  E Boersma; A C Maas; J W Deckers; M L Simoons
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

  2 in total
  4 in total

1.  A qualitative study of paramedics' attitudes to providing prehospital thrombolysis.

Authors:  L Price; P Keeling; G Brown; D Hughes; A Barton
Journal:  Emerg Med J       Date:  2005-10       Impact factor: 2.740

2.  Retrospective observational case-control study comparing prehospital thrombolytic therapy for ST-elevation myocardial infarction with in-hospital thrombolytic therapy for patients from same area.

Authors:  M S V M Chittari; I Ahmad; B Chambers; F Knight; A Scriven; D Pitcher
Journal:  Emerg Med J       Date:  2005-08       Impact factor: 2.740

3.  Limited benefits of ambulance telemetry in delivering early thrombolysis: a randomised controlled trial.

Authors:  M Woollard; K Pitt; A J Hayward; N C Taylor
Journal:  Emerg Med J       Date:  2005-03       Impact factor: 2.740

4.  Utilization, Safety, and Technical Performance of a Telemedicine System for Prehospital Emergency Care: Observational Study.

Authors:  Marc Felzen; Stefan Kurt Beckers; Felix Kork; Frederik Hirsch; Sebastian Bergrath; Anja Sommer; Jörg Christian Brokmann; Michael Czaplik; Rolf Rossaint
Journal:  J Med Internet Res       Date:  2019-10-08       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.